"","PMID","title","setting","abx_appropriate_for_resistancetype","abx_appropriate_exist","abx_type","resistance_type","bacteria_reported","bacteria_grp","colonisation_site","abx_dur","time_baseline_endoffu","n_ind_contributedsamples","n_ind_outcome","outcome_distribution"
"1","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU",NA,"YES",NA,"Aminoglycoside","Gram negatives","Gram negatives","Gut","0","Point prevalence surveys","171.0000","10.000","poisson"
"2","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU",NA,"YES",NA,"Fluoroquinolone","Gram negatives","Gram negatives","Gut","0","Point prevalence surveys","171.0000","10.800","poisson"
"3","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU",NA,"YES",NA,"Cephalosporin","Gram negatives","Gram negatives","Gut","0","Point prevalence surveys","171.0000","12.820","poisson"
"4","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU",NA,"YES",NA,"Aminoglycosides, gentamicin, tobramycin, ciprofloxacin, ceftazidime","Gram negatives","Gram negatives","Gut","0","Point prevalence surveys","171.0000","7.100","poisson"
"5","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Aminoglycoside","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","165.0000","4.100","poisson"
"6","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Fluoroquinolone","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","165.0000","4.800","poisson"
"7","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Cephalosporin","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","165.0000","4.120","poisson"
"8","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Aminoglycosides, gentamicin, tobramycin, ciprofloxacin, ceftazidime","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","165.0000","3.400","poisson"
"9","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU",NA,"YES",NA,"Aminoglycoside","Gram negatives","Gram negatives","Respiratory tract","0","Point prevalence surveys","149.0000","7.400","poisson"
"10","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU",NA,"YES",NA,"Fluoroquinolone","Gram negatives","Gram negatives","Respiratory tract","0","Point prevalence surveys","149.0000","8.200","poisson"
"11","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU",NA,"YES",NA,"Cephalosporin","Gram negatives","Gram negatives","Respiratory tract","0","Point prevalence surveys","149.0000","10.200","poisson"
"12","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU",NA,"YES",NA,"Aminoglycosides, gentamicin, tobramycin, ciprofloxacin, ceftazidime","Gram negatives","Gram negatives","Respiratory tract","0","Point prevalence surveys","149.0000","7.100","poisson"
"13","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Aminoglycoside","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","149.0000","12.600","poisson"
"14","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Fluoroquinolone","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","149.0000","1.900","poisson"
"15","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Cephalosporin","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","149.0000","1.600","poisson"
"16","19118302","Decontamination of the digestive tract and oropharynx in ICU patients","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Aminoglycosides, gentamicin, tobramycin, ciprofloxacin, ceftazidime","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","149.0000","1.000","poisson"
"17","18454864","Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study","ICU",NA,"NO",NA,"Ceftazidime or imipenem-resistant","Gram negatives","Gram negatives","Respiratory tract","0","36","26.0000","5.000","binomial"
"18","18454864","Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study","ICU",NA,"YES",NA,"Meticillin","Staph aureus","Gram positives","Respiratory tract","0","36","26.0000","0.000","binomial"
"19","18454864","Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study","ICU",NA,"YES",NA,"ESBL-producing","Gram negatives","Gram negatives","Respiratory tract","0","36","26.0000","3.000","binomial"
"20","18454864","Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study","ICU","NO","NO","Culture directed","Ceftazidime or imipenem-resistant","Gram negatives","Gram negatives","Respiratory tract","8","40","18.0000","3.000","binomial"
"21","18454864","Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study","ICU","YES","YES","Culture directed","Meticillin","Staph aureus","Gram positives","Respiratory tract","8","40","18.0000","1.000","binomial"
"22","18454864","Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study","ICU","YES","YES","Culture directed","ESBL-producing","Gram negatives","Gram negatives","Respiratory tract","8","40","18.0000","2.000","binomial"
"23","11434826","Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","Outpatient",NA,"YES",NA,"Penicillin","Pneumococcus","Gram positives","Respiratory tract","0","1","795.0000","210.000","binomial"
"24","11434826","Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","Outpatient",NA,"YES",NA,"Amoxicillin","Pneumococcus","Gram positives","Respiratory tract","0","1","795.0000","3.000","binomial"
"25","11434826","Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","Outpatient",NA,"YES",NA,"Trimethoprim-sulfamethoxazole","Pneumococcus","Gram positives","Respiratory tract","0","1","795.0000","157.000","binomial"
"26","11434826","Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","Outpatient","YES","YES","Amoxicillin","Penicillin","Pneumococcus","Gram positives","Respiratory tract","5","5","740.0000","151.650","binomial"
"27","11434826","Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","Outpatient","YES","YES","Amoxicillin","Penicillin","Pneumococcus","Gram positives","Respiratory tract","5","10","364.0000","83.720","binomial"
"28","11434826","Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","Outpatient","YES","YES","Amoxicillin","Penicillin","Pneumococcus","Gram positives","Respiratory tract","10","10","358.0000","71.600","binomial"
"29","11434826","Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","Outpatient","YES","YES","Amoxicillin","Penicillin","Pneumococcus","Gram positives","Respiratory tract","5","28","355.0000","85.200","binomial"
"30","11434826","Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","Outpatient","YES","YES","Amoxicillin","Penicillin","Pneumococcus","Gram positives","Respiratory tract","10","28","346.0000","110.720","binomial"
"31","11434826","Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","Outpatient","NO","YES","Amoxicillin","Trimethoprim-sulfamethoxazole","Pneumococcus","Gram positives","Respiratory tract","5","28","355.0000","62.000","binomial"
"32","11434826","Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","Outpatient","NO","YES","Amoxicillin","Trimethoprim-sulfamethoxazole","Pneumococcus","Gram positives","Respiratory tract","10","28","346.0000","81.000","binomial"
"33","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Amoxicillin","E coli","Enterobacteriaceae","Urine","0","1","60.0000","5.000","binomial"
"34","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Amoxicillin","E coli","Enterobacteriaceae","Urine","0","7","30.0000","2.000","binomial"
"35","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU","YES","YES","Culture directed","Amoxicillin","E coli","Enterobacteriaceae","Urine","3","7","30.0000","2.000","binomial"
"36","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Amoxicillin","E coli","Enterobacteriaceae","Urine","0","15","30.0000","0.000","binomial"
"37","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU","YES","YES","Culture directed","Amoxicillin","E coli","Enterobacteriaceae","Urine","3","15","30.0000","2.000","binomial"
"38","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Amox-clav","Enterobacteriaceae","Enterobacteriaceae","Urine","0","1","60.0000","11.000","binomial"
"39","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Amox-clav","Enterobacteriaceae","Enterobacteriaceae","Urine","0","7","30.0000","1.000","binomial"
"40","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU","YES","YES","Culture directed","Amox-clav","Enterobacteriaceae","Enterobacteriaceae","Urine","3","7","30.0000","1.000","binomial"
"41","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Amox-clav","Enterobacteriaceae","Enterobacteriaceae","Urine","0","15","30.0000","1.000","binomial"
"42","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU","YES","YES","Culture directed","Amox-clav","Enterobacteriaceae","Enterobacteriaceae","Urine","3","15","30.0000","1.000","binomial"
"43","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Ticacillin","Non fermenters","Non fermenters","Urine","0","1","60.0000","11.000","binomial"
"44","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Ticacillin","Non fermenters","Non fermenters","Urine","0","7","30.0000","4.000","binomial"
"45","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU","YES","YES","Culture directed","Ticacillin","Non fermenters","Non fermenters","Urine","3","7","30.0000","2.000","binomial"
"46","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Ticacillin","Non fermenters","Non fermenters","Urine","0","15","30.0000","2.000","binomial"
"47","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU","YES","YES","Culture directed","Ticacillin","Non fermenters","Non fermenters","Urine","3","15","30.0000","2.000","binomial"
"48","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Cefotaxime","Citrobacter","Enterobacteriaceae","Urine","0","1","60.0000","0.000","binomial"
"49","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Cefotaxime","Citrobacter","Enterobacteriaceae","Urine","0","7","30.0000","0.000","binomial"
"50","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU","YES","YES","Culture directed","Cefotaxime","Citrobacter","Enterobacteriaceae","Urine","3","7","30.0000","1.000","binomial"
"51","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Cefotaxime","Citrobacter","Enterobacteriaceae","Urine","0","15","30.0000","0.000","binomial"
"52","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU","YES","YES","Culture directed","Cefotaxime","Citrobacter","Enterobacteriaceae","Urine","3","15","30.0000","0.000","binomial"
"53","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Amoxicillin","Enterococcus","Gram positives","Urine","0","1","60.0000","8.000","binomial"
"54","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Amoxicillin","Enterococcus","Gram positives","Urine","0","7","30.0000","2.000","binomial"
"55","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU","YES","YES","Culture directed","Amoxicillin","Enterococcus","Gram positives","Urine","3","7","30.0000","1.000","binomial"
"56","17294169","A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients","ICU",NA,"YES",NA,"Amoxicillin","Enterococcus","Gram positives","Urine","0","15","30.0000","1.000","binomial"
"57","17484870","High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants","Neonatal unit",NA,"YES",NA,"Meticillin","Staph aureus","Gram positives","Gut","0","1","75.0000","0.000","binomial"
"58","17484870","High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants","Neonatal unit",NA,"YES",NA,"Meticillin","Staph aureus","Gram positives","Gut","0","10","38.0000","1.000","binomial"
"59","17484870","High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants","Neonatal unit","NO","YES","Erythromycin","Meticillin","Staph aureus","Gram positives","Gut","10","10","37.0000","0.000","binomial"
"60","17484870","High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants","Neonatal unit",NA,"YES",NA,"Meticillin","Staph aureus","Gram positives","Gut","0","42","38.0000","0.000","binomial"
"61","17484870","High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants","Neonatal unit","NO","YES","Erythromycin","Meticillin","Staph aureus","Gram positives","Gut","14","42","37.0000","0.000","binomial"
"62","15356779","A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury","Outpatient","NO","YES","Ciprofloxacin","Fluoroquinolone","Gram negatives","Gram negatives","Urine","3","42","30.0000","8.000","binomial"
"63","15356779","A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury","Outpatient","NO","YES","Ciprofloxacin","Fluoroquinolone","Gram negatives","Gram negatives","Urine","14","42","30.0000","5.000","binomial"
"64","28002709","Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children","Outpatient",NA,"YES",NA,"Penicillin","Pneumococcus","Gram positives","Respiratory tract","0","1","514.0000","85.000","binomial"
"65","28002709","Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children","Outpatient",NA,"YES",NA,"Beta-lactamase producing","H influenzae","Gram negatives","Respiratory tract","0","1","514.0000","55.000","binomial"
"66","28002709","Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children","Outpatient","YES","YES","Amox-clav","Penicillin","Pneumococcus","Gram positives","Respiratory tract","5","14","222.0000","26.000","binomial"
"67","28002709","Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children","Outpatient","NO","YES","Amox-clav","Beta-lactamase producing","H influenzae","Gram negatives","Respiratory tract","5","14","222.0000","28.000","binomial"
"68","28002709","Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children","Outpatient","YES","YES","Amox-clav","Penicillin","Pneumococcus","Gram positives","Respiratory tract","10","14","233.0000","23.000","binomial"
"69","28002709","Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children","Outpatient","NO","YES","Amox-clav","Beta-lactamase producing","H influenzae","Gram negatives","Respiratory tract","10","14","233.0000","38.000","binomial"
"70","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"YES",NA,"Ceftazidime","Gram negatives","Gram negatives","Gut and respiratory tract","0","1","868.0000","7.000","binomial"
"71","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"YES",NA,"Ciprofloxacin","Gram negatives","Gram negatives","Gut and respiratory tract","0","1","868.0000","29.000","binomial"
"72","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"NO",NA,"Imipenem","Gram negatives","Gram negatives","Gut and respiratory tract","0","1","868.0000","2.000","binomial"
"73","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"NO",NA,"Polymyxin","Gram negatives","Gram negatives","Gut and respiratory tract","0","1","868.0000","0.000","binomial"
"74","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"YES",NA,"Tobramycin","Gram negatives","Gram negatives","Gut and respiratory tract","0","1","868.0000","47.000","binomial"
"75","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"YES",NA,"Vancomycin","Enterococcus","Gram positives","Gut and respiratory tract","0","1","868.0000","10.000","binomial"
"76","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"YES",NA,"Meticillin","Staph aureus","Gram positives","Gut and respiratory tract","0","1","868.0000","0.000","binomial"
"77","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"YES",NA,"Ceftazidime","Gram negatives","Gram negatives","Gut and respiratory tract","0","15.5","395.0000","21.000","binomial"
"78","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"YES",NA,"Ciprofloxacin","Gram negatives","Gram negatives","Gut and respiratory tract","0","15.5","395.0000","44.000","binomial"
"79","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"NO",NA,"Imipenem","Gram negatives","Gram negatives","Gut and respiratory tract","0","15.5","395.0000","26.000","binomial"
"80","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"NO",NA,"Polymyxin","Gram negatives","Gram negatives","Gut and respiratory tract","0","15.5","395.0000","2.000","binomial"
"81","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"YES",NA,"Tobramycin","Gram negatives","Gram negatives","Gut and respiratory tract","0","15.5","395.0000","60.000","binomial"
"82","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"YES",NA,"Vancomycin","Enterococcus","Gram positives","Gut and respiratory tract","0","15.5","395.0000","5.000","binomial"
"83","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU",NA,"YES",NA,"Meticillin","Staph aureus","Gram positives","Gut and respiratory tract","0","15.5","395.0000","0.000","binomial"
"84","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Ceftazidime","Pseudomonas","Non fermenters","Gut and respiratory tract","4","13.8","378.0000","9.000","binomial"
"85","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Ciprofloxacin","Pseudomonas","Non fermenters","Gut and respiratory tract","4","13.8","378.0000","10.000","binomial"
"86","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU","NO","NO","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Imipenem","Pseudomonas","Non fermenters","Gut and respiratory tract","4","13.8","378.0000","2.000","binomial"
"87","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU","NO","NO","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Polymyxin","Pseudomonas","Non fermenters","Gut and respiratory tract","4","13.8","378.0000","4.000","binomial"
"88","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Tobramycin","Pseudomonas","Non fermenters","Gut and respiratory tract","4","13.8","378.0000","33.000","binomial"
"89","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU","NO","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Vancomycin","Enterococcus","Gram positives","Gut and respiratory tract","4","13.8","378.0000","4.000","binomial"
"90","14522530","Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial","ICU","NO","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Meticillin","Staph aureus","Gram positives","Gut and respiratory tract","4","13.8","378.0000","0.000","binomial"
"91","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","HRMO","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","1928.0000","140.000","poisson"
"92","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","ESBL-producing","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","1928.0000","85.000","poisson"
"93","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Aminoglycoside","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","1928.0000","109.000","poisson"
"94","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Ciprofloxacin","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","1928.0000","108.000","poisson"
"95","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","NO","NO","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Carbapenem","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","1928.0000","30.000","poisson"
"96","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","NO","NO","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Colistin","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","1928.0000","23.000","poisson"
"97","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","NO","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Vancomycin","Enterococcus","Gram positives","Gut","4","Point prevalence surveys","1928.0000","11.000","poisson"
"98","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","HRMO","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","1840.0000","47.000","poisson"
"99","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","ESBL-producing","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","1840.0000","24.000","poisson"
"100","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Aminoglycoside","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","1840.0000","50.000","poisson"
"101","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","YES","YES","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Ciprofloxacin","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","1840.0000","46.000","poisson"
"102","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","NO","NO","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Carbapenem","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","1840.0000","15.000","poisson"
"103","25271544","Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial","ICU","NO","NO","Combination (cefotaxime, tobramycin, colistin, amphotericin B)","Colistin","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","1840.0000","12.000","poisson"
"104","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"HRMO","Enterobacteriaceae","Enterobacteriaceae","Gut","0","Point prevalence surveys","1456.0000","234.416","poisson"
"105","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"ESBL-producing","Gram negatives","Gram negatives","Gut","0","Point prevalence surveys","1456.0000","230.048","poisson"
"106","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"NO",NA,"Carbapenem","Gram negatives","Gram negatives","Gut","0","Point prevalence surveys","1456.0000","46.592","poisson"
"107","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"Resistance to >3 classes/antibiotics","Gram negatives","Gram negatives","Gut","0","Point prevalence surveys","1456.0000","157.248","poisson"
"108","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"NO",NA,"Colistin","Gram negatives","Gram negatives","Gut","0","Point prevalence surveys","1456.0000","7.280","poisson"
"109","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"HRMO","Non fermenters","Non fermenters","Gut","0","Point prevalence surveys","1456.0000","46.592","poisson"
"110","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"NO",NA,"Carbapenem","Non fermenters","Non fermenters","Gut","0","Point prevalence surveys","1456.0000","42.224","poisson"
"111","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"NO",NA,"Colistin","Non fermenters","Non fermenters","Gut","0","Point prevalence surveys","1456.0000","0.000","poisson"
"112","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"Resistance to >3 classes/antibiotics","Non fermenters","Non fermenters","Gut","0","Point prevalence surveys","1456.0000","34.944","poisson"
"113","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"Gentamicin","Gram negatives","Gram negatives","Gut","0","Point prevalence surveys","1456.0000","120.848","poisson"
"114","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"Vancomycin","Enterococcus","Gram positives","Gut","0","Point prevalence surveys","1456.0000","32.032","poisson"
"115","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","HRMO","Enterobacteriaceae","Enterobacteriaceae","Gut","4","Point prevalence surveys","1407.0000","195.573","poisson"
"116","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","ESBL-producing","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","1407.0000","192.759","poisson"
"117","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","NO","NO","Combination (colistin, tobramycin, and nystatin)","Carbapenem","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","1407.0000","36.582","poisson"
"118","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","Resistance to >3 classes/antibiotics","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","1407.0000","140.700","poisson"
"119","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","NO","NO","Combination (colistin, tobramycin, and nystatin)","Colistin","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","1407.0000","18.291","poisson"
"120","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","HRMO","Non fermenters","Non fermenters","Gut","4","Point prevalence surveys","1407.0000","32.361","poisson"
"121","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","NO","NO","Combination (colistin, tobramycin, and nystatin)","Carbapenem","Non fermenters","Non fermenters","Gut","4","Point prevalence surveys","1407.0000","25.326","poisson"
"122","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","NO","NO","Combination (colistin, tobramycin, and nystatin)","Colistin","Non fermenters","Non fermenters","Gut","4","Point prevalence surveys","1407.0000","4.221","poisson"
"123","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","Resistance to >3 classes/antibiotics","Non fermenters","Non fermenters","Gut","4","Point prevalence surveys","1407.0000","23.919","poisson"
"124","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","NO","YES","Combination (colistin, tobramycin, and nystatin)","Vancomycin","Enterococcus","Gram positives","Gut","4","Point prevalence surveys","1407.0000","59.094","poisson"
"125","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","Gentamicin","Gram negatives","Gram negatives","Gut","4","Point prevalence surveys","1407.0000","101.304","poisson"
"126","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"HRMO","Enterobacteriaceae","Enterobacteriaceae","Respiratory tract","0","Point prevalence surveys","1456.0000","96.096","poisson"
"127","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"ESBL-producing","Gram negatives","Gram negatives","Respiratory tract","0","Point prevalence surveys","1456.0000","93.184","poisson"
"128","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"NO",NA,"Carbapenem","Gram negatives","Gram negatives","Respiratory tract","0","Point prevalence surveys","1456.0000","20.384","poisson"
"129","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"Resistance to >3 classes/antibiotics","Gram negatives","Gram negatives","Respiratory tract","0","Point prevalence surveys","1456.0000","58.240","poisson"
"130","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"NO",NA,"Colistin","Gram negatives","Gram negatives","Respiratory tract","0","Point prevalence surveys","1456.0000","1.456","poisson"
"131","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"HRMO","Non fermenters","Non fermenters","Respiratory tract","0","Point prevalence surveys","1456.0000","49.504","poisson"
"132","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"NO",NA,"Carbapenem","Non fermenters","Non fermenters","Respiratory tract","0","Point prevalence surveys","1456.0000","45.136","poisson"
"133","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"NO",NA,"Colistin","Non fermenters","Non fermenters","Respiratory tract","0","Point prevalence surveys","1456.0000","4.368","poisson"
"134","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"Resistance to >3 classes/antibiotics","Non fermenters","Non fermenters","Respiratory tract","0","Point prevalence surveys","1456.0000","36.400","poisson"
"135","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"Meticillin","Staph aureus","Gram positives","Respiratory tract","0","Point prevalence surveys","1456.0000","24.752","poisson"
"136","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU",NA,"YES",NA,"Gentamicin","Gram negatives","Gram negatives","Respiratory tract","0","Point prevalence surveys","1456.0000","55.328","poisson"
"137","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","HRMO","Enterobacteriaceae","Enterobacteriaceae","Respiratory tract","4","Point prevalence surveys","1407.0000","66.129","poisson"
"138","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","ESBL-producing","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","1407.0000","63.315","poisson"
"139","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","NO","NO","Combination (colistin, tobramycin, and nystatin)","Carbapenem","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","1407.0000","7.035","poisson"
"140","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","Resistance to >3 classes/antibiotics","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","1407.0000","49.245","poisson"
"141","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","NO","NO","Combination (colistin, tobramycin, and nystatin)","Colistin","Gram negatives","Gram negatives","Respiratory tract","4","Point prevalence surveys","1407.0000","4.221","poisson"
"142","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","HRMO","Non fermenters","Non fermenters","Respiratory tract","4","Point prevalence surveys","1407.0000","37.989","poisson"
"143","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","NO","NO","Combination (colistin, tobramycin, and nystatin)","Carbapenem","Non fermenters","Non fermenters","Respiratory tract","4","Point prevalence surveys","1407.0000","33.768","poisson"
"144","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","NO","NO","Combination (colistin, tobramycin, and nystatin)","Colistin","Non fermenters","Non fermenters","Respiratory tract","4","Point prevalence surveys","1407.0000","2.814","poisson"
"145","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","Resistance to >3 classes/antibiotics","Non fermenters","Non fermenters","Respiratory tract","4","Point prevalence surveys","1407.0000","30.954","poisson"
"146","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","NO","YES","Combination (colistin, tobramycin, and nystatin)","Meticillin","Staph aureus","Gram positives","Respiratory tract","4","Point prevalence surveys","1407.0000","23.919","poisson"
"147","30347072","Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial","ICU","YES","YES","Combination (colistin, tobramycin, and nystatin)","Gentamicin","Staph aureus","Gram positives","Respiratory tract","4","Point prevalence surveys","1407.0000","56.280","poisson"
"148","16392777","Acute uncomplicated lower urinary tract infections in general practice: Clinical and microbiological cute rates after three- versus five-day treatment with trimethoprim","Outpatient",NA,"YES",NA,"Trimethoprim-sulfamethoxazole","E coli","Enterobacteriaceae","Urine","0","1","128.9583","13.000","binomial"
"149","16392777","Acute uncomplicated lower urinary tract infections in general practice: Clinical and microbiological cute rates after three- versus five-day treatment with trimethoprim","Outpatient","NO","YES","Trimethoprim-sulfamethoxazole","Trimethoprim-sulfamethoxazole","E coli","Enterobacteriaceae","Urine","1","2","127.4436","18.000","binomial"
"150","16392777","Acute uncomplicated lower urinary tract infections in general practice: Clinical and microbiological cute rates after three- versus five-day treatment with trimethoprim","Outpatient","NO","YES","Trimethoprim-sulfamethoxazole","Trimethoprim-sulfamethoxazole","E coli","Enterobacteriaceae","Urine","3","4","126.7857","17.000","binomial"
"151","18478129","Preventive antibacterial therapy in acute ischemic stroke: A randomized controlled trial","Hospital",NA,"YES",NA,"Fluoroquinolone","E coli","Enterobacteriaceae","Gut","0","1","59.0000","1.000","binomial"
"152","18478129","Preventive antibacterial therapy in acute ischemic stroke: A randomized controlled trial","Hospital",NA,"YES",NA,"Fluoroquinolone","E coli","Enterobacteriaceae","Gut","0","9","20.0000","1.000","binomial"
"153","18478129","Preventive antibacterial therapy in acute ischemic stroke: A randomized controlled trial","Hospital","NO","YES","Moxfloxacin","Fluoroquinolone","E coli","Enterobacteriaceae","Gut","5","9","20.0000","1.000","binomial"
"154","18513453","Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: A randomized controlled trial","Outpatient",NA,"YES",NA,"Penicillin","Pneumococcus","Gram positives","Respiratory tract","0","1","103.0000","32.910","binomial"
"155","18513453","Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: A randomized controlled trial","Outpatient",NA,"YES",NA,"Beta-lactamase producing","H influenzae","Gram negatives","Respiratory tract","0","1","103.0000","4.140","binomial"
"156","18513453","Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: A randomized controlled trial","Outpatient",NA,"YES",NA,"Penicillin","Pneumococcus","Gram positives","Respiratory tract","0","168","47.0000","19.000","binomial"
"157","18513453","Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: A randomized controlled trial","Outpatient","NO","YES","Amoxicillin","Beta-lactamase producing","H influenzae","Gram negatives","Respiratory tract","171","168","50.0000","17.000","binomial"
"158","18513453","Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: A randomized controlled trial","Outpatient",NA,"YES",NA,"Penicillin","Pneumococcus","Gram positives","Respiratory tract","0","168","47.0000","1.000","binomial"
"159","18513453","Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: A randomized controlled trial","Outpatient","NO","YES","Amoxicillin","Beta-lactamase producing","H influenzae","Gram negatives","Respiratory tract","171","168","50.0000","6.000","binomial"
"160","18818954","Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children","Hospital",NA,"YES",NA,"Trimethoprim-sulfamethoxazole","Gram negatives","Gram negatives","Urine","0","1","128.0000","0.000","binomial"
"161","18818954","Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children","Hospital",NA,"YES",NA,"Ceftibuten","Gram negatives","Gram negatives","Urine","0","1","255.0000","0.000","binomial"
"162","18818954","Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children","Hospital","NO","YES","Trimethoprim-sulfamethoxazole","Trimethoprim-sulfamethoxazole","Gram negatives","Gram negatives","Urine","10","11","128.0000","4.000","binomial"
"163","18818954","Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children","Hospital","NO","YES","Trimethoprim-sulfamethoxazole","Ceftibuten","Gram negatives","Gram negatives","Urine","10","11","255.0000","0.000","binomial"
"164","18818954","Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children","Hospital","NO","YES","Ceftibuten","Trimethoprim-sulfamethoxazole","Gram negatives","Gram negatives","Urine","10","11","128.0000","1.000","binomial"
"165","18818954","Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children","Hospital","NO","YES","Ceftibuten","Ceftibuten","Gram negatives","Gram negatives","Urine","10","11","255.0000","0.000","binomial"
"166","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Fosfomycin trometamol","Gram negatives","Gram negatives","Urine","0","1","260.0000","10.000","binomial"
"167","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Fosfomycin trometamol","Enterococcus","Gram positives","Urine","0","1","260.0000","0.000","binomial"
"168","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Fosfomycin trometamol","Staph saprophyticus","Gram positives","Urine","0","1","260.0000","1.000","binomial"
"169","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"NO",NA,"Imipenem","Gram negatives","Gram negatives","Urine","0","1","260.0000","1.000","binomial"
"170","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Ceftriaxone","Gram negatives","Gram negatives","Urine","0","1","260.0000","20.000","binomial"
"171","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Ciprofloxacin","Gram negatives","Gram negatives","Urine","0","1","260.0000","54.000","binomial"
"172","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Ciprofloxacin","Staph saprophyticus","Gram positives","Urine","0","1","260.0000","1.000","binomial"
"173","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Levofloxacin","Gram negatives","Gram negatives","Urine","0","1","260.0000","34.000","binomial"
"174","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Levofloxacin","Staph saprophyticus","Gram positives","Urine","0","1","260.0000","1.000","binomial"
"175","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Trimethoprim-sulfamethoxazole","Gram negatives","Gram negatives","Urine","0","1","260.0000","74.000","binomial"
"176","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Trimethoprim-sulfamethoxazole","Staph saprophyticus","Gram positives","Urine","0","1","260.0000","2.000","binomial"
"177","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Gentamicin","Gram negatives","Gram negatives","Urine","0","1","260.0000","57.000","binomial"
"178","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Gentamicin","Enterococcus","Gram positives","Urine","0","1","260.0000","0.000","binomial"
"179","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Ampicillin","Gram negatives","Gram negatives","Urine","0","1","260.0000","105.000","binomial"
"180","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient",NA,"YES",NA,"Ampicillin","Enterococcus","Gram positives","Urine","0","1","260.0000","1.000","binomial"
"181","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient","NO","YES","Fosfomycin trometamol","Fosfomycin trometamol","Gram negatives","Gram negatives","Urine","1","8","130.0000","8.000","binomial"
"182","20585969","A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","Outpatient","NO","YES","Ciprofloxacin","Ciprofloxacin","Gram negatives","Gram negatives","Urine","5","8","130.0000","12.000","binomial"
"183","21269858","Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media","Outpatient",NA,"YES",NA,"Penicillin","Pneumococcus","Gram positives","Respiratory tract","0","1","565.0000","86.000","binomial"
"184","21269858","Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media","Outpatient",NA,"YES",NA,"Beta-lactamase producing","M catarhalis","Gram negatives","Respiratory tract","0","1","565.0000","58.000","binomial"
"185","21269858","Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media","Outpatient",NA,"YES",NA,"Oxacillin","Staph aureus","Gram positives","Respiratory tract","0","1","565.0000","2.000","binomial"
"186","21269858","Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media","Outpatient",NA,"YES",NA,"Azithromycin","Pneumococcus","Gram positives","Respiratory tract","0","1","282.0000","25.000","binomial"
"187","21269858","Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media","Outpatient",NA,"YES",NA,"Amox-clav","H influenzae","Gram negatives","Respiratory tract","0","1","565.0000","1.000","binomial"
"188","21269858","Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media","Outpatient",NA,"YES",NA,"Amox-clav","Pneumococcus","Gram positives","Respiratory tract","0","1","283.0000","4.000","binomial"
"189","21269858","Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media","Outpatient",NA,"YES",NA,"Penicillin","Pneumococcus","Gram positives","Respiratory tract","0","5","93.0000","18.000","binomial"
"190","21269858","Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media","Outpatient",NA,"YES",NA,"Beta-lactamase producing","M catarhalis","Gram negatives","Respiratory tract","0","5","93.0000","0.000","binomial"
"191","21269858","Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media","Outpatient",NA,"YES",NA,"Beta-lactamase producing","H influenzae","Gram negatives","Respiratory tract","0","5","93.0000","1.000","binomial"
"192","21269858","Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media","Outpatient",NA,"YES",NA,"Penicillin","Pneumococcus","Gram positives","Respiratory tract","0","5","116.0000","16.000","binomial"
"193","21269858","Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media","Outpatient",NA,"YES",NA,"Beta-lactamase producing","H influenzae","Gram negatives","Respiratory tract","0","5","116.0000","1.000","binomial"
"194","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient",NA,"YES",NA,"Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","0","1","35.0000","0.000","binomial"
"195","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","14","30","17.0000","0.000","binomial"
"196","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","30","30","11.0000","0.000","binomial"
"197","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","14","60","17.0000","0.000","binomial"
"198","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","60","60","11.0000","0.000","binomial"
"199","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","14","90","17.0000","0.000","binomial"
"200","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","90","90","11.0000","0.000","binomial"
"201","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","14","120","17.0000","0.000","binomial"
"202","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","104","120","11.0000","0.000","binomial"
"203","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","14","150","17.0000","0.000","binomial"
"204","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","104","150","11.0000","0.000","binomial"
"205","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","14","210","17.0000","0.000","binomial"
"206","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","104","210","11.0000","0.000","binomial"
"207","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","14","270","17.0000","0.000","binomial"
"208","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","104","270","11.0000","0.000","binomial"
"209","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","14","360","17.0000","0.000","binomial"
"210","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","104","360","11.0000","0.000","binomial"
"211","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","14","450","11.0000","0.000","binomial"
"212","26340658","Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","Outpatient","YES","YES","Tobramycin and ceftzidime","Tobramycin","Pseudomonas","Non fermenters","Respiratory tract","104","450","17.0000","0.000","binomial"
"213","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Amoxicillin","E coli","Enterobacteriaceae","Urine","0","1","220.0000","100.000","binomial"
"214","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Amoxicillin","E coli","Enterobacteriaceae","Urine","0","180","68.0000","41.000","binomial"
"215","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Amoxicillin","E coli","Enterobacteriaceae","Urine","180","180","68.0000","32.000","binomial"
"216","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Amoxicillin","E coli","Enterobacteriaceae","Urine","0","365","67.0000","35.000","binomial"
"217","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Amoxicillin","E coli","Enterobacteriaceae","Urine","365","365","67.0000","37.000","binomial"
"218","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Cefalexin","E coli","Enterobacteriaceae","Urine","0","1","225.0000","11.000","binomial"
"219","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Cefalexin","E coli","Enterobacteriaceae","Urine","0","180","68.0000","5.000","binomial"
"220","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Cefalexin","E coli","Enterobacteriaceae","Urine","180","180","67.0000","5.000","binomial"
"221","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Cefalexin","E coli","Enterobacteriaceae","Urine","0","365","67.0000","6.000","binomial"
"222","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Cefalexin","E coli","Enterobacteriaceae","Urine","365","365","75.0000","5.000","binomial"
"223","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Ciprofloxacin","E coli","Enterobacteriaceae","Urine","0","1","219.0000","5.000","binomial"
"224","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Ciprofloxacin","E coli","Enterobacteriaceae","Urine","0","180","68.0000","5.000","binomial"
"225","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Ciprofloxacin","E coli","Enterobacteriaceae","Urine","180","180","68.0000","5.000","binomial"
"226","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Ciprofloxacin","E coli","Enterobacteriaceae","Urine","0","365","67.0000","5.000","binomial"
"227","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Ciprofloxacin","E coli","Enterobacteriaceae","Urine","365","365","67.0000","5.000","binomial"
"228","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Trimethoprim-sulfamethoxazole","E coli","Enterobacteriaceae","Urine","0","1","218.0000","58.000","binomial"
"229","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Trimethoprim-sulfamethoxazole","E coli","Enterobacteriaceae","Urine","0","180","68.0000","16.000","binomial"
"230","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Trimethoprim-sulfamethoxazole","E coli","Enterobacteriaceae","Urine","180","180","68.0000","18.000","binomial"
"231","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Trimethoprim-sulfamethoxazole","E coli","Enterobacteriaceae","Urine","0","365","67.0000","25.000","binomial"
"232","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Trimethoprim-sulfamethoxazole","E coli","Enterobacteriaceae","Urine","365","365","67.0000","17.000","binomial"
"233","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Amox-clav","E coli","Enterobacteriaceae","Urine","0","1","217.0000","14.000","binomial"
"234","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Amox-clav","E coli","Enterobacteriaceae","Urine","0","180","68.0000","7.000","binomial"
"235","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Amox-clav","E coli","Enterobacteriaceae","Urine","180","180","67.0000","2.000","binomial"
"236","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Amox-clav","E coli","Enterobacteriaceae","Urine","0","365","67.0000","5.000","binomial"
"237","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Amox-clav","E coli","Enterobacteriaceae","Urine","365","365","75.0000","5.000","binomial"
"238","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Mecillinam","E coli","Enterobacteriaceae","Urine","0","1","215.0000","5.000","binomial"
"239","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Mecillinam","E coli","Enterobacteriaceae","Urine","0","180","68.0000","0.000","binomial"
"240","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","NO","YES","Nitrofurantoin, trimethoprim or cefalexin","Mecillinam","E coli","Enterobacteriaceae","Urine","180","180","68.0000","1.000","binomial"
"241","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Mecillinam","E coli","Enterobacteriaceae","Urine","0","365","67.0000","2.000","binomial"
"242","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","NO","YES","Nitrofurantoin, trimethoprim or cefalexin","Mecillinam","E coli","Enterobacteriaceae","Urine","365","365","66.0000","0.000","binomial"
"243","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Nitrofurantoin","E coli","Enterobacteriaceae","Urine","0","1","215.0000","1.000","binomial"
"244","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Nitrofurantoin","E coli","Enterobacteriaceae","Urine","0","180","68.0000","1.000","binomial"
"245","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Nitrofurantoin","E coli","Enterobacteriaceae","Urine","180","180","68.0000","4.000","binomial"
"246","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Nitrofurantoin","E coli","Enterobacteriaceae","Urine","0","365","67.0000","3.000","binomial"
"247","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Nitrofurantoin","E coli","Enterobacteriaceae","Urine","365","365","66.0000","2.000","binomial"
"248","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Trimethoprim","E coli","Enterobacteriaceae","Urine","0","1","215.0000","67.000","binomial"
"249","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Trimethoprim","E coli","Enterobacteriaceae","Urine","0","180","68.0000","31.000","binomial"
"250","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Trimethoprim","E coli","Enterobacteriaceae","Urine","180","180","68.0000","20.000","binomial"
"251","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient",NA,"YES",NA,"Trimethoprim","E coli","Enterobacteriaceae","Urine","0","365","67.0000","31.000","binomial"
"252","29766842","Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: The AnTIC RCT","Outpatient","YES","YES","Nitrofurantoin, trimethoprim or cefalexin","Trimethoprim","E coli","Enterobacteriaceae","Urine","365","365","66.0000","20.000","binomial"
"253","31821452","Increased risk of acquisition and transmission of ESBL-producing Enterobacteriaceae in malnourished children exposed to amoxicillin","Outpatient",NA,"YES",NA,"ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","0","1","468.0000","141.000","binomial"
"254","31821452","Increased risk of acquisition and transmission of ESBL-producing Enterobacteriaceae in malnourished children exposed to amoxicillin","Outpatient",NA,"YES",NA,"ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","0","7","161.0000","52.000","binomial"
"255","31821452","Increased risk of acquisition and transmission of ESBL-producing Enterobacteriaceae in malnourished children exposed to amoxicillin","Outpatient","NO","YES","Amoxicillin","ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","7","7","147.0000","79.000","binomial"
"256","31821452","Increased risk of acquisition and transmission of ESBL-producing Enterobacteriaceae in malnourished children exposed to amoxicillin","Outpatient",NA,"YES",NA,"ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","0","28","117.0000","16.000","binomial"
"257","31821452","Increased risk of acquisition and transmission of ESBL-producing Enterobacteriaceae in malnourished children exposed to amoxicillin","Outpatient","NO","YES","Amoxicillin","ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","7","28","96.0000","8.000","binomial"
"258","30853250","Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial","Outpatient",NA,"YES",NA,"ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","0","1","90.0000","11.000","binomial"
"259","30853250","Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial","Outpatient",NA,"YES",NA,"Meticillin","Staph aureus","Gram positives","Respiratory tract","0","1","131.0000","0.000","binomial"
"260","30853250","Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial","Outpatient","NO","YES","Flucloxacillin","ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","8","10","33.0000","4.000","binomial"
"261","30853250","Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial","Outpatient","NO","YES","Flucloxacillin","Meticillin","Staph aureus","Gram positives","Respiratory tract","8","10","35.0000","0.000","binomial"
"262","30853250","Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial","Hospital","NO","YES","Ceftiaxone","ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","8","10","48.0000","10.000","binomial"
"263","30853250","Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial","Hospital","NO","YES","Ceftiaxone","Meticillin","Staph aureus","Gram positives","Respiratory tract","8","10","49.0000","0.000","binomial"
"264","30853250","Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial","Outpatient","NO","YES","Flucloxacillin","ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","8","90","35.0000","7.000","binomial"
"265","30853250","Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial","Outpatient","NO","YES","Flucloxacillin","Meticillin","Staph aureus","Gram positives","Respiratory tract","8","90","34.0000","0.000","binomial"
"266","30853250","Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial","Hospital","NO","YES","Ceftiaxone","ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","8","90","44.0000","8.000","binomial"
"267","30853250","Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial","Hospital","NO","YES","Ceftiaxone","Meticillin","Staph aureus","Gram positives","Respiratory tract","8","90","54.0000","1.000","binomial"
"268","32130261","Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial","ICU",NA,"NO",NA,"Carbapenem","Gram negatives","Gram negatives","Gut","0","1","195.0000","0.000","binomial"
"269","32130261","Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial","ICU","NO","NO","Meropenem","Carbapenem","Gram negatives","Gram negatives","Gut","8","28","101.0000","19.000","binomial"
"270","32130261","Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial","ICU","NO","NO","Ampicillin+gentamicin or cefotaxime+gentamicin","Carbapenem","Gram negatives","Gram negatives","Gut","7","28","94.0000","7.000","binomial"
"271","32267724","Targeted retreatment of incompletely recovered chronic obstructive pulmonary disease exacerbations with ciprofloxacin a double-blind, randomized, placebo-controlled, multicenter, phase III clinical trial","Outpatient",NA,"YES",NA,"Ciprofloxacin","Bacteria","Unspecified","Respiratory tract","0","1","47.0000","1.000","binomial"
"272","32267724","Targeted retreatment of incompletely recovered chronic obstructive pulmonary disease exacerbations with ciprofloxacin a double-blind, randomized, placebo-controlled, multicenter, phase III clinical trial","Outpatient",NA,"YES",NA,"Ciprofloxacin","Bacteria","Unspecified","Respiratory tract","0","90","17.0000","1.000","binomial"
"273","32267724","Targeted retreatment of incompletely recovered chronic obstructive pulmonary disease exacerbations with ciprofloxacin a double-blind, randomized, placebo-controlled, multicenter, phase III clinical trial","Outpatient","NO","YES","Ciprofloxacin","Ciprofloxacin","Bacteria","Unspecified","Respiratory tract","7","90","16.0000","0.000","binomial"
"274","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"YES",NA,"ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","0","1","78.0000","3.000","binomial"
"275","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"NO",NA,"Carbapenem","Gram negatives","Gram negatives","Gut","0","1","78.0000","3.000","binomial"
"276","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"YES",NA,"Tobramycin","Gram negatives","Gram negatives","Gut","0","1","78.0000","26.000","binomial"
"277","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"NO",NA,"Colistin","Gram negatives","Gram negatives","Gut","0","1","78.0000","13.000","binomial"
"278","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"YES",NA,"ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","0","30","28.0000","1.000","binomial"
"279","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"NO",NA,"Carbapenem","Gram negatives","Gram negatives","Gut","0","30","28.0000","1.000","binomial"
"280","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"YES",NA,"Tobramycin","Gram negatives","Gram negatives","Gut","0","30","28.0000","10.000","binomial"
"281","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"NO",NA,"Colistin","Gram negatives","Gram negatives","Gut","0","30","28.0000","4.000","binomial"
"282","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital","YES","YES","Combination (tobramycin and colistin sulphate)","ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","3","30","34.0000","1.000","binomial"
"283","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital","NO","NO","Combination (tobramycin and colistin sulphate)","Carbapenem","Gram negatives","Gram negatives","Gut","3","30","34.0000","0.000","binomial"
"284","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital","YES","YES","Combination (tobramycin and colistin sulphate)","Tobramycin","Gram negatives","Gram negatives","Gut","3","30","34.0000","15.000","binomial"
"285","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital","NO","NO","Combination (tobramycin and colistin sulphate)","Colistin","Gram negatives","Gram negatives","Gut","3","30","34.0000","4.000","binomial"
"286","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"YES",NA,"ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","0","1","78.0000","3.000","binomial"
"287","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"NO",NA,"Carbapenem","Gram negatives","Gram negatives","Gut","0","1","78.0000","3.000","binomial"
"288","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"YES",NA,"Tobramycin","Gram negatives","Gram negatives","Gut","0","1","78.0000","26.000","binomial"
"289","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"NO",NA,"Colistin","Gram negatives","Gram negatives","Gut","0","1","78.0000","13.000","binomial"
"290","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"YES",NA,"ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","0","30","28.0000","1.000","binomial"
"291","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"NO",NA,"Carbapenem","Gram negatives","Gram negatives","Gut","0","30","28.0000","1.000","binomial"
"292","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"YES",NA,"Tobramycin","Gram negatives","Gram negatives","Gut","0","30","28.0000","10.000","binomial"
"293","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital",NA,"NO",NA,"Colistin","Gram negatives","Gram negatives","Gut","0","30","28.0000","4.000","binomial"
"294","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital","YES","YES","Combination (tobramycin and colistin sulphate)","ESBL-producing","Enterobacteriaceae","Enterobacteriaceae","Gut","3","30","34.0000","1.000","binomial"
"295","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital","NO","NO","Combination (tobramycin and colistin sulphate)","Carbapenem","Gram negatives","Gram negatives","Gut","3","30","34.0000","0.000","binomial"
"296","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital","YES","YES","Combination (tobramycin and colistin sulphate)","Tobramycin","Gram negatives","Gram negatives","Gut","3","30","34.0000","15.000","binomial"
"297","32539786","Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: Results of a multicenter randomized placebo-controlled clinical trial","Hospital","NO","NO","Combination (tobramycin and colistin sulphate)","Colistin","Gram negatives","Gram negatives","Gut","3","30","34.0000","4.000","binomial"
"298","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Ciprofloxacin","Gram negatives","Gram negatives","Gut or respiratory tract","0","1","207.0000","2.000","binomial"
"299","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Ciprofloxacin","Staph aureus","Gram positives","Gut or respiratory tract","0","1","207.0000","2.000","binomial"
"300","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Ciprofloxacin","Enterococcus","Gram positives","Gut or respiratory tract","0","1","207.0000","4.000","binomial"
"301","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Gram negatives","Gram negatives","Gut or respiratory tract","0","1","207.0000","5.000","binomial"
"302","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Staph aureus","Gram positives","Gut or respiratory tract","0","1","207.0000","1.000","binomial"
"303","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Enterococcus","Gram positives","Gut or respiratory tract","0","1","207.0000","33.000","binomial"
"304","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"NO",NA,"Polymyxin","Gram negatives","Gram negatives","Gut or respiratory tract","0","1","207.0000","15.000","binomial"
"305","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU","YES","YES","Combination (ciprofloxacin, gentamicin and polymyxin)","Ciprofloxacin","Gram negatives","Gram negatives","Gut or respiratory tract","4","1","175.0000","2.000","binomial"
"306","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU","YES","YES","Combination (ciprofloxacin, gentamicin and polymyxin)","Ciprofloxacin","Staph aureus","Gram positives","Gut or respiratory tract","4","1","175.0000","3.000","binomial"
"307","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU","YES","YES","Combination (ciprofloxacin, gentamicin and polymyxin)","Ciprofloxacin","Enterococcus","Gram positives","Gut or respiratory tract","4","1","175.0000","13.000","binomial"
"308","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU","YES","YES","Combination (ciprofloxacin, gentamicin and polymyxin)","Gentamicin","Gram negatives","Gram negatives","Gut or respiratory tract","4","1","175.0000","8.000","binomial"
"309","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU","YES","YES","Combination (ciprofloxacin, gentamicin and polymyxin)","Gentamicin","Staph aureus","Gram positives","Gut or respiratory tract","4","1","175.0000","6.000","binomial"
"310","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU","YES","YES","Combination (ciprofloxacin, gentamicin and polymyxin)","Gentamicin","Enterococcus","Gram positives","Gut or respiratory tract","4","1","175.0000","53.000","binomial"
"311","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU","NO","NO","Combination (ciprofloxacin, gentamicin and polymyxin)","Polymyxin","Gram negatives","Gram negatives","Gut or respiratory tract","4","1","175.0000","16.000","binomial"
"312","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU","NO","YES","Combination (ciprofloxacin, gentamicin and polymyxin)","Oxacillin","Staph aureus","Gram positives","Gut or respiratory tract","4","1","175.0000","2.000","binomial"
"313","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU","NO","NO","Combination (ciprofloxacin, gentamicin and polymyxin)","Polymyxin","Gram negatives","Gram negatives","Gut or respiratory tract","4","1","144.0000","10.000","binomial"
"314","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU","NO","YES","Combination (ciprofloxacin, gentamicin and polymyxin)","Oxacillin","Staph aureus","Gram positives","Gut or respiratory tract","4","1","144.0000","1.000","binomial"
"315","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Ciprofloxacin","Gram negatives","Gram negatives","Gut or respiratory tract","0","1","203.0000","1.000","binomial"
"316","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Ciprofloxacin","Staph aureus","Gram positives","Gut or respiratory tract","0","1","203.0000","2.000","binomial"
"317","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Ciprofloxacin","Enterococcus","Gram positives","Gut or respiratory tract","0","1","203.0000","5.000","binomial"
"318","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Gram negatives","Gram negatives","Gut or respiratory tract","0","1","203.0000","4.000","binomial"
"319","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Staph aureus","Gram positives","Gut or respiratory tract","0","1","203.0000","2.000","binomial"
"320","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Enterococcus","Gram positives","Gut or respiratory tract","0","1","203.0000","39.000","binomial"
"321","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"NO",NA,"Polymyxin","Gram negatives","Gram negatives","Gut or respiratory tract","0","1","203.0000","22.000","binomial"
"322","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Oxacillin","Staph aureus","Gram positives","Gut or respiratory tract","0","1","203.0000","1.000","binomial"
"323","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Ciprofloxacin","Gram negatives","Gram negatives","Gut or respiratory tract","0","28","171.0000","5.000","binomial"
"324","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Ciprofloxacin","Staph aureus","Gram positives","Gut or respiratory tract","0","28","171.0000","9.000","binomial"
"325","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Ciprofloxacin","Enterococcus","Gram positives","Gut or respiratory tract","0","28","171.0000","18.000","binomial"
"326","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Gram negatives","Gram negatives","Gut or respiratory tract","0","28","171.0000","12.000","binomial"
"327","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Staph aureus","Gram positives","Gut or respiratory tract","0","28","171.0000","11.000","binomial"
"328","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Enterococcus","Gram positives","Gut or respiratory tract","0","28","171.0000","88.000","binomial"
"329","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"NO",NA,"Polymyxin","Gram negatives","Gram negatives","Gut or respiratory tract","0","28","171.0000","37.000","binomial"
"330","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Oxacillin","Staph aureus","Gram positives","Gut or respiratory tract","0","28","171.0000","7.000","binomial"
"331","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Ciprofloxacin","Staph aureus","Gram positives","Gut or respiratory tract","0","56","138.0000","4.000","binomial"
"332","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Ciprofloxacin","Enterococcus","Gram positives","Gut or respiratory tract","0","56","138.0000","3.000","binomial"
"333","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Pseudomonas","Non fermenters","Gut or respiratory tract","0","56","138.0000","3.000","binomial"
"334","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Staph aureus","Gram positives","Gut or respiratory tract","0","56","138.0000","4.000","binomial"
"335","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"YES",NA,"Gentamicin","Enterococcus","Gram positives","Gut or respiratory tract","0","56","138.0000","30.000","binomial"
"336","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"NO",NA,"Polymyxin","Gram negatives","Gram negatives","Gut or respiratory tract","0","56","138.0000","12.000","binomial"
"337","12379544","Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical tr","ICU",NA,"NO",NA,"Polymyxin","Staph aureus","Gram positives","Gut or respiratory tract","0","56","138.0000","1.000","binomial"
